Deep-Ultraviolet Resonance Raman (DUVRR) Spectroscopy of Therapeutic Monoclonal Antibodies Subjected to Thermal Stress
- 1 July 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 87 (15) , 7880-7886
Abstract
The structural assessment of Rituximab, an IgG1 mAb, was investigated with deep-ultraviolet resonance Raman (DUVRR) spectroscopy. DUVRR spectroscopy was used to monitor the changes to the secondary structure of Rituximab under thermal stress. DUVRR spectra showed obvious changes from 22 to 72 °C. Specifically, changes in the amide I vibrational mode were assigned to an increase in unordered structure (random coil). Structural changes in samples heated to 72 °C were related to loss in drug potency via a complement dependent cytotoxicity (CDC) bioassay. The DUVRR spectroscopic method shows promise as a tool for the quality assessment of mAb drug products and would represent an improvement over current methodology in terms of analysis time and sample preparation. To determine the scope of the method, protein pharmaceuticals of different molecular weights (ranging from 4 to 143 kDa) and secondary structure (β-sheet, α-helix and unordered structure) were analyzed. The model illustrated the method’s sensitivity for the analysis of protein drug products of different secondary structure. Results show promise for DUVRR spectroscopy as a rapid screening tool of a variety of formulated protein pharmaceuticals.Keywords
Funding Information
- U.S. Food and Drug Administration
This publication has 23 references indexed in Scilit:
- Use of Raman and Raman optical activity for the structural characterization of a therapeutic monoclonal antibody formulation subjected to heat stressJournal of Raman Spectroscopy, 2015
- Mapping Monoclonal Antibody Structure by 2D 13C NMR at Natural AbundanceAnalytical Chemistry, 2015
- Circular Dichroism Spectroscopy as a Tool for Monitoring Aggregation in Monoclonal Antibody TherapeuticsAnalytical Chemistry, 2014
- Perspectives on Well-Characterized Biological Proteins2014
- Heterogeneity of IgGs: Role of Production, Processing, and Storage on Structure and Function2014
- Aggregates in monoclonal antibody manufacturing processesBiotechnology and Bioengineering, 2011
- Aggregation of a multidomain protein: A coagulation mechanism governs aggregation of a model IgG1 antibody under weak thermal stressProtein Science, 2009
- Therapeutic Monoclonal Antibodies2009
- Effects of protein aggregates: An immunologic perspectiveThe AAPS Journal, 2006
- Bioequivalence and the immunogenicity of biopharmaceuticalsNature Reviews Drug Discovery, 2002